To the full analysis
Buyback calculator for Axsome Therapeutics
Axsome Therapeutics stock: key metrics
AXSMAxsome Therapeutics had an operating margin of −26.5% and a return on invested capital (ROIC) of −37% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2013 | no data | no data | no data |
| 2014 | no data | no data | no data |
| 2015 | no data | no data | no data |
| 2016 | no data | no data | no data |
| 2017 | no data | no data | no data |
| 2018 | no data | no data | no data |
| 2019 | no data | no data | no data |
| 2020 | no data | no data | no data |
| 2021 | no data | no data | no data |
| 2022 | 89.6% | −359.3% | −374.0% |
| 2023 | 90.4% | −85.7% | −88.4% |
| 2024 | 91.4% | −72.7% | −74.5% |
| 2025 | 92.6% | −26.5% | −28.7% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2013 | 106.8% | −80.8% | −100.0% |
| 2014 | 187.4% | no data | −100.0% |
| 2015 | −26.3% | −30.1% | −24.9% |
| 2016 | −100.0% | −56.0% | −71.2% |
| 2017 | −100.0% | −74.0% | −81.4% |
| 2018 | −100.0% | no data | −100.0% |
| 2019 | −38.2% | −51.4% | −31.0% |
| 2020 | −90.4% | −43.3% | −55.3% |
| 2021 | −100.0% | −86.6% | −100.0% |
| 2022 | −100.0% | −94.8% | −56.5% |
| 2023 | −100.0% | −53.5% | −40.7% |
| 2024 | −100.0% | −56.3% | −50.5% |
| 2025 | −100.0% | −37.0% | −26.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Nov 2016)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.